A meta-analytic approach to estimating nocebo effects in neuropathic pain trials
- 3 August 2011
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 259 (3) , 436-447
Abstract
The development of non-specific adverse effects following the administration of an active or inert substance is referred to as nocebo phenomenon. We aimed to estimate the frequency and severity of nocebo responses in clinical trials of pharmacological treatments for neuropathic pain. A systematic Medline search for all randomized, placebo-controlled neuropathic pain trials published between 2000 and 2010 was carried out. Meta-analysis of the frequency of nocebo responses was performed by pooling the percentage of placebo-treated patients that exhibited drug-related adverse events. Nocebo severity was calculated from the percentage of placebo-treated patients that dropped out due to drug-related adverse events. The pooled frequency of nocebo responses in neuropathic pain trials was 52.0% (95% CI: 35.7–67.9) and the pooled nocebo severity was 6.0% (95% CI: 4.5–8.0). Meta-regression analysis revealed an association between the frequency of nocebo responses and the percentage of females in the placebo-treated group (p = 0.0028). Furthermore, nocebo severity displayed a significant association with the study population (p = 0.0386). Our data indicates a powerful nocebo effect in neuropathic pain trials that may be influenced by gender- and population-related factors. A strong nocebo effect may be adversely affecting adherence and efficacy of current treatments for neuropathic pain in clinical practice.Keywords
This publication has 50 references indexed in Scilit:
- Nocebo effects in multiple sclerosis trials: a meta-analysisMultiple Sclerosis Journal, 2010
- Pregabalin for painful HIV neuropathyNeurology, 2010
- Placebo and nocebo effects in randomized double‐blind clinical trials of agents for the therapy for fatigue in patients with advanced cancerCancer, 2009
- Neuropathic PainPharmacoEconomics, 2009
- New Insights into the Placebo and Nocebo ResponsesNeuron, 2008
- Neuropathic painNeurology, 2008
- Placebo Effects in Oral Triptan Trials: the Scientific and Ethical Rationale for Continued use of Placebo ControlsCephalalgia, 2005
- Medication side effects in anxious patients: Negative placebo responses?Journal of Affective Disorders, 1998
- The Role of Personality Factors in the Reporting of Side Effect Complaints to Moclobemide and PlaceboJournal of Clinical Psychopharmacology, 1995
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986